Alembic Pharmaceuticals planning to raise Rs 350 crore via NCDs

10 Dec 2018 Evaluate

Alembic Pharmaceuticals is planning to the issue and allotment of Unsecured Listed Redeemable Non-Convertible Debentures (NCDs) of up to Rs 350 crore on Private Placement Basis. The meeting of the NCD Committee of the company will be held on December 14, 2018, inter-alia to consider and approve the same.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Alembic Pharma Share Price

762.55 -6.00 (-0.78%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×